These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. BCR/ABL P190 transgenic mice develop leukemia in the absence of Crkl. Hemmeryckx B; Reichert A; Watanabe M; Kaartinen V; de Jong R; Pattengale PK; Groffen J; Heisterkamp N Oncogene; 2002 May; 21(20):3225-31. PubMed ID: 12082638 [TBL] [Abstract][Full Text] [Related]
11. Nilotinib treatment in mouse models of P190 Bcr/Abl lymphoblastic leukemia. Kaur P; Feldhahn N; Zhang B; Trageser D; Müschen M; Pertz V; Groffen J; Heisterkamp N Mol Cancer; 2007 Oct; 6():67. PubMed ID: 17958915 [TBL] [Abstract][Full Text] [Related]
12. Leukemogenesis of b2a2-type p210 BCR/ABL in a bone marrow transplantation mouse model using a lentiviral vector. Uchida N; Hanawa H; Dan K; Inokuchi K; Shimada T J Nippon Med Sch; 2009 Jun; 76(3):134-47. PubMed ID: 19602820 [TBL] [Abstract][Full Text] [Related]
13. Ribozyme-mediated inhibition of a Philadelphia chromosome-positive acute lymphoblastic leukemia cell line expressing the p190 bcr-abl oncogene. Snyder DS; Wu Y; McMahon R; Yu L; Rossi JJ; Forman SJ Biol Blood Marrow Transplant; 1997 Oct; 3(4):179-86. PubMed ID: 9360779 [TBL] [Abstract][Full Text] [Related]
14. A BCR-ABL(p190) fusion gene made by homologous recombination causes B-cell acute lymphoblastic leukemias in chimeric mice with independence of the endogenous bcr product. Castellanos A; Pintado B; Weruaga E; Arévalo R; López A; Orfao A; Sánchez-García I Blood; 1997 Sep; 90(6):2168-74. PubMed ID: 9310467 [TBL] [Abstract][Full Text] [Related]
15. The src homology 2 domain of Bcr/Abl is required for efficient induction of chronic myeloid leukemia-like disease in mice but not for lymphoid leukemogenesis or activation of phosphatidylinositol 3-kinase. Roumiantsev S; de Aos IE; Varticovski L; Ilaria RL; Van Etten RA Blood; 2001 Jan; 97(1):4-13. PubMed ID: 11133737 [TBL] [Abstract][Full Text] [Related]
16. Chronic myelogenous leukemia: molecular and cellular aspects. Pasternak G; Hochhaus A; Schultheis B; Hehlmann R J Cancer Res Clin Oncol; 1998; 124(12):643-60. PubMed ID: 9879825 [TBL] [Abstract][Full Text] [Related]
17. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. Li S; Ilaria RL; Million RP; Daley GQ; Van Etten RA J Exp Med; 1999 May; 189(9):1399-412. PubMed ID: 10224280 [TBL] [Abstract][Full Text] [Related]
18. Establishment of a cell line with variant BCR/ABL breakpoint expressing P180BCR/ABL from late-appearing Philadelphia-positive acute biphenotypic leukemia. Inokuchi K; Shinohara T; Futaki M; Hanawa H; Tanosaki S; Yamaguchi H; Nomura T; Dan K Genes Chromosomes Cancer; 1998 Nov; 23(3):227-38. PubMed ID: 9790503 [TBL] [Abstract][Full Text] [Related]
19. Pre-B acute lymphoblastic leukemia with b3a2 (p210) and e1a2 (p190) BCR-ABL fusion transcripts relapsing as chronic myelogenous leukemia with a less differentiated b3a2 (p210) clone. Winter SS; Greene JM; McConnell TS; Willman CL Leukemia; 1999 Dec; 13(12):2007-11. PubMed ID: 10602422 [TBL] [Abstract][Full Text] [Related]